This study aimed to detect BCR::ABL1 KD mutations in CML patients with treatment resistance and assess the concordance between NGS (next generation sequencing) and Sanger sequencing (SS) in detecting these mutations. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.